ReviewCancer immunology, immunotherapy : CII2014
Interleukin 12: still a promising candidate for tumor immunotherapy?
Witold Lasek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
277 papers cite itlatest 60 shown
this papertrialcites it